Oliveira A, Pereira J, Nunes G, Sousa Junior I, Sarmento D, Lopes J
Braz J Infect Dis. 2025; 29(2):104508.
PMID: 39922051
PMC: 11848753.
DOI: 10.1016/j.bjid.2025.104508.
Sunil-Chandra N, Jayasundara M, Gunathilaka M, Suminda S
BMC Infect Dis. 2025; 25(1):184.
PMID: 39920600
PMC: 11806834.
DOI: 10.1186/s12879-025-10594-2.
da Rocha A, Rodrigues G, da Silva Hellwig A, Pereira D, Volpato F, Barth A
Diagnostics (Basel). 2025; 15(2).
PMID: 39857098
PMC: 11765014.
DOI: 10.3390/diagnostics15020214.
Guimaraes A, Raposo Vedovi J, de Almeida Ribeiro C, Martinelli K, Machado M, de Abreu Manso P
Int J Mol Sci. 2024; 25(14).
PMID: 39062747
PMC: 11276870.
DOI: 10.3390/ijms25147502.
Ribeiro R, Lacerda K, Guillo L
Indian J Dermatol. 2023; 68(5):588.
PMID: 38099098
PMC: 10718258.
DOI: 10.4103/ijd.ijd_950_22.
A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production.
Frozza F, Fazolo T, de Souza P, Lima K, da Fontoura J, Borba T
Med Microbiol Immunol. 2022; 212(1):75-91.
PMID: 36512097
PMC: 9745694.
DOI: 10.1007/s00430-022-00758-1.
Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis.
Skipper C, Hullsiek K, Cresswell F, Tadeo K, Okirwoth M, Blackstad M
Int J Infect Dis. 2022; 122:785-792.
PMID: 35843498
PMC: 9653033.
DOI: 10.1016/j.ijid.2022.07.035.
Herpesvirus and neurological manifestations in patients with severe coronavirus disease.
de Souza Carneiro V, Alves-Leon S, Sarmento D, da Costa Nunes Pimentel Coelho W, Moreira O, Salvio A
Virol J. 2022; 19(1):101.
PMID: 35676707
PMC: 9174631.
DOI: 10.1186/s12985-022-01828-9.
Human Cytomegalovirus Seroprevalence Among Blood Donors in the Madinah Region, Saudi Arabia.
Mahallawi W, Khabour O, Al-Saedi A, Almuzaini Z, Ibrahim N
Cureus. 2022; 14(2):e21860.
PMID: 35265404
PMC: 8897812.
DOI: 10.7759/cureus.21860.
Prevalence and Recurrence Rates of Cytomegalovirus Infection Among Patients With Hematological Diseases in the Western Brazilian Amazon: A Cross-Sectional Study.
Silva J, Pinheiro-Silva R, de Oliveira R, de Castro Alves C, Barbosa A, Pontes G
Front Public Health. 2021; 9:692226.
PMID: 34692617
PMC: 8529106.
DOI: 10.3389/fpubh.2021.692226.
Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis.
Adane T, Getawa S
J Int Med Res. 2021; 49(8):3000605211034656.
PMID: 34382466
PMC: 8366145.
DOI: 10.1177/03000605211034656.
Clinical validation of an in-house quantitative real time PCR assay for cytomegalovirus infection using the 1st WHO International Standard in kidney transplant patients.
Caurio C, Allende O, Kist R, Santos K, Vasconcellos I, Rozales F
J Bras Nefrol. 2021; 43(4):530-538.
PMID: 33970997
PMC: 8940123.
DOI: 10.1590/2175-8239-JBN-2020-0214.
RISK FACTORS FOR POST-LIVER TRANSPLANT BILIARY COMPLICATIONS IN THE ABSENCE OF ARTERIAL COMPLICATIONS.
Lima A, Pereira B, Jungmann S, Machado C, Correia M
Arq Bras Cir Dig. 2020; 33(3):e1541.
PMID: 33331436
PMC: 7747483.
DOI: 10.1590/0102-672020200003e1541.
The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review.
Al Mana H, Yassine H, Younes N, Al-Mohannadi A, Al-Sadeq D, Alhababi D
Pathogens. 2019; 8(4).
PMID: 31683687
PMC: 6963600.
DOI: 10.3390/pathogens8040213.
Blood donor safety, prevalence and associated factors for cytomegalovirus infection among blood donors in Minna-Nigeria, 2014.
Bawa M, Mamman A, Olayinka A, Gidado S, Waziri N, Balogun M
Pan Afr Med J. 2019; 32(Suppl 1):6.
PMID: 30984327
PMC: 6445335.
DOI: 10.11604/pamj.supp.2019.32.1.13297.
Cytomegalovirus infection among Human Immunodeficiency Virus (HIV) infected individuals on highly active anti-retroviral therapy in North-Central Nigeria.
Udeze A, Odebisi-Omokanye M, Ajileye T
Afr Health Sci. 2019; 18(4):1057-1065.
PMID: 30766572
PMC: 6354892.
DOI: 10.4314/ahs.v18i4.27.
Investigation on the association between thyroid tumorigeneses and herpesviruses.
Almeida J, Campos A, Marcello M, Bufalo N, Rossi C, Amaral L
J Endocrinol Invest. 2017; 40(8):823-829.
PMID: 28276007
DOI: 10.1007/s40618-017-0609-y.
Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation.
Resende C, Rezende B, Bernardes P, Teixeira G, Teixeira M, Pinho V
Braz J Med Biol Res. 2017; 50(2):e5566.
PMID: 28198910
PMC: 5343562.
DOI: 10.1590/1414-431X20165566.
Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China.
Wang S, Wang T, Zhang W, Liu X, Wang X, Wang H
Medicine (Baltimore). 2017; 96(5):e6007.
PMID: 28151899
PMC: 5293462.
DOI: 10.1097/MD.0000000000006007.
Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey.
Ibrahim S, Siddiqui A, Siddiqui A, Ahmed W, Moss P, Lalani E
BMC Public Health. 2016; 16(1):1112.
PMID: 27770770
PMC: 5075404.
DOI: 10.1186/s12889-016-3772-8.